FDA.reportPublic FDA data

olanzapine 210 MG Injection

RxCUI
1718934
RxNorm name
olanzapine 210 MG Injection
Display name
olanzapine 210 MG Injection
Full name
olanzapine 210 MG Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:47

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ZYPREXA RelprevvOLANZAPINE PAMOATEH2-Pharma LLC11544cba-64a9-49cb-8d74-da228053b2522026-05-19Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1718934

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
11544cba-64a9-49cb-8d74-da228053b252OLANZapine 210 MG Extended Release Injection [PSN] · olanzapine 210 MG Injection [SCD] · olanzapine 210 MG (as olanzapine pamoate monohydrate 483 MG) Injection [SY]368These highlights do not include all the information needed to use ZYPREXA RELPREVV safely and effectively. See full prescribing information for ZYPREXA RELPREVV. ZYPREXA RELPREVV (olanzapine) For Extended Release Injectable Suspension Initial U.S. Approval: 199620260519